246
Views
0
CrossRef citations to date
0
Altmetric
Research Articles

Utility of Pyrimidine Thione Derivatives in the Synthesis of Biologically Active Heterocyclic Compounds

ORCID Icon, , , ORCID Icon &
Pages 2618-2643 | Received 15 Jul 2021, Accepted 27 Feb 2022, Published online: 15 Mar 2022

References

  • V. S. Dinakaran, D. Jacob, and J. E. Mathew, “Synthesis and Biological Evaluation of Novel Pyrimidine-2(1H)-Ones/Thiones as Potent Anti-Inflammatory and Anticancer Agents,” Medicinal Chemistry Research 21, no. 11 (2012): 3598–606. doi:10.1007/s00044-011-9909-5.
  • Ehsan Ullah Mughal, Amina Sadiq, Muhammad Hamayun, Muhammad Naveed Zafar, Nighat Fatima, Muhammad Arfat Yameen, Syed Aun Muhammad, Amara Mumtaz, Ishtiaq Ahmed, and Tehseen Fatima, “Design, Synthesis and Biological Evaluation of Novel Dihydropyrimidine-2-Thione Derivatives as Potent Antimicrobial Agents: Experimental and Molecular Docking Approach,” Letters in Drug Design & Discovery 15, no. 11 (2018): 1189–201. doi:10.2174/1570180815666180209151516.
  • T. I. El-Emary, S. A. Abdel-Mohsen, and S. A. Mohamed, “An Efficient Synthesis and Reactions of 5-Acetyl-6-Methyl-4-(1,3-Diphenyl-1H-Pyrazol-4-yl)-3,4-Dihydropyrmidin-2 (1H)-Thione as Potential Antimicrobial and anti-Inflammatory Agents,” Russian Journal of Bioorganic Chemistry 47, no. 2 (2021): 561–71. doi:10.1134/S1068162021020102.
  • N. Khaldi-Khellafi, M. Makhloufi-Chebli, D. Oukacha-Hikem, S. T. Bouaziz, K. O. Lamara, T. Idir, A. Benazzouz-Touami, and F. Dumas, “Green Synthesis, Antioxidant and Antibacterial Activities of 4-Aryl-3, 4-Dihydropyrimidinones/Thiones Derivatives of Curcumin. Theoretical Calculations and Mechanism Study,” Journal of Molecular Structure 1181 (2019): 261–9. doi:10.1016/j.molstruc.2018.12.104.
  • S. Pandey, P. Pandey, S. S. Gautam, and J. Singh, “Synthesis, Characterization and Antifungal Evaluation of Substituted Pyrimidin-2-Thione Derivatives,” Research Journal of Pharmacy and Technology 14, no. 1 (2021): 275–9. doi:10.5958/0974-360X.2021.00049.4.
  • S. Sheikhi-Mohammareh, A. Shiri, H. Beyzaei, and E. Yarmohammadi, “New Efficient Design and Synthesis of Novel Antioxidant and Antifungal 7-Imino[1, 3]Selenazolo[4,5-d]Pyrimidine-5 (4H)-Thiones Utilizing a Base-Promoted Cascade Addition/Cyclization Sequence,” Monatshefte für Chemie – Chemical Monthly 151, no. 6 (2020): 963–9. doi:10.1007/s00706-020-02617-2.
  • P. T. Mistry, N. R. Kamdar, D. D. Haveliwala, and S. K. Patel, “Concise and Facile Synthesis of Novel Pyrano [2,3-d] Pyrimidine-7-One/Thione Derivatives as In Vitro Antimicrobial and Antitubercular Agents,” Letters in Drug Design & Discovery 8, no. 8 (2011): 750–7.
  • S. M. Rajesh, R. S. Kumar, L. A. Libertsen, S. Perumal, P. Yogeeswari, and D. Sriram, “A Green Expedient Synthesis of Pyridopyrimidine-2-Thiones and Their Antitubercular Activity,” Bioorganic & Medicinal Chemistry Letters 21, no. 10 (2011): 3012–6. doi:10.1016/j.bmcl.2011.03.045.
  • M. Sahu, N. Siddiqui, R. Iqbal, V. Sharma, and S. Wakode, “Design, Synthesis and Evaluation of Newer 5,6-Dihydropyrimidine-2(1H)-Thiones as GABA-AT Inhibitors for Anticonvulsant Potential,” Bioorganic Chemistry 74 (2017): 166–78. doi:10.1016/j.bioorg.2017.07.017.
  • Ning-Yu Wang, Wei-Qiong Zuo, Ying Xu, Chao Gao, Xiu-Xiu Zeng, Li-Dan Zhang, Xin-Yu You, Cui-Ting Peng, Yang Shen, Sheng-Yong Yang, et al, “Discovery and Structure–Activity Relationships Study of Novel Thieno[2,3-b]Pyridine Analogues as Hepatitis C Virus Inhibitors,” Bioorganic & Medicinal Chemistry Letters 24, no. 6 (2014): 1581–8. doi:10.1016/j.bmcl.2014.01.075.
  • Fawzy Attaby, Azza Abdel-Fattah, Labeeb Shaif, and Mohamed Elsayed, “Elsayed MM: Reactions, Anti-Alzheimer and Anti Cox-2 Activities of the Newly Synthesized 2-Substituted Thienopyridines,” Current Organic Chemistry 13, no. 16 (2009): 1654–63. doi:10.2174/138527209789578135.
  • Eslam M. H. Ali, Mohammed S. Abdel-Maksoud, and Chang-Hyun Oh, “Thieno[2,3-d]Pyrimidine as a Promising Scaffold in Medicinal Chemistry: Recent Advances,” Bioorganic & Medicinal Chemistry 27, no. 7 (2019): 1159–94. doi:10.1016/j.bmc.2019.02.044.
  • C. R. Cardoso, F. C. F. de Brito, K. C. M. da Silva, A. L. P. de Miranda, C. A. M. Fraga, and E. J. Barreiro, “Design, Synthesis and Pharmacological Evaluation of Novel Pyrazolo[3,4-b]Thieno[2,3-d]Pyridine Acid Derivatives: A New Class of Anti-Inflammatory and Anti-Platelet Agents,” Bioorganic & Medicinal Chemistry Letters 12, no. 1 (2002): 9–12. doi:10.1016/S0960-894X(01)00651-5.
  • M. M. Abdulla, A. E. Amr, M. A. Al-Omar, A. A. Hussain, and A. F. A. Shalaby, “Anti-Inflammatory Activity and Acute Toxicity (LD 50) of Some New Synthesized Pyridine-2-yl-Phenyl)-2-Methoxybenzamide and Thieno [2, 3-b] Pyridine Derivatives,” Life Science Journal 10 (2013): 286–97.
  • A. E. M. Mekky, S. M. H. Sanad, A. Y. Said, and M. A. A. Elneairy, “Synthesis, Cytotoxicity, In-Vitro Antibacterial Screening and In-Silico Study of Novel Thieno[2,3-b]Pyridines as Potential Pim-1 Inhibitors,” Synthetic Communications 50, no. 15 (2020): 2376–89. doi:10.1080/00397911.2020.1778033.
  • I. Pevet, C. Brulé, A. Tizot, A. Gohier, F. Cruzalegui, J. A. Boutin, and S. Goldstein, “Synthesis and Pharmacological Evaluation of Thieno[2,3-b]Pyridine Derivatives as Novel c-Src Inhibitors,” Bioorganic & Medicinal Chemistry 19, no. 8 (2011): 2517–28. doi:10.1016/j.bmc.2011.03.021.
  • Rajesh H. Bahekar, Mukul R. Jain, Pradip A. Jadav, Vijay M. Prajapati, Dipam N. Patel, Arun A. Gupta, Ajay Sharma, Robby Tom, Debdutta Bandyopadhya, Honey Modi, et al, “Synthesis and Antidiabetic Activity of 2,5-Disubstituted-3-Imidazol-2-yl-pyrrolo[2,3-b]Pyridines and Thieno[2,3-b]Pyridines,” Bioorganic & Medicinal Chemistry 15, no. 21 (2007): 6782–95. doi:10.1016/j.bmc.2007.08.005.
  • A. M. R. Bernardino, L. C. S. Pinheiro, V. F. Ferreira, and A. R. Azevedo, “Synthesis and Antiviral Activity of New 4-(Phenylamino) Thieno [2, 3-b] Pyridine Derivatives,” Heterocyclic Communications 10, no. 6 (2004): 407–10. doi:10.1515/HC.2004.10.6.407.
  • Mark E. Schnute, Michele M. Cudahy, Roger J. Brideau, Fred L. Homa, Todd A. Hopkins, Mary L. Knechtel, Nancee L. Oien, Thomas W. Pitts, Roger A. Poorman, Michael W. Wathen, et al, “4-Oxo-4,7-Dihydrothieno[2,3-b]Pyridines as Non-Nucleoside Inhibitors of Human Cytomegalovirus and Related Herpesvirus Polymerases,” Journal of Medicinal Chemistry 48, no. 18 (2005): 5794–804. doi:10.1021/jm050162b.
  • M. Alkheilewi, “Characterisation of Androgen Receptor Variants in Breast Cancer and the Development of Thieno[2,3-b]Pyridines as Novel anti-Cancer Compounds,” PhD Thesis. (2019). University of Essex.‏
  • Homayon J. Arabshahi, Michelle van Rensburg, Lisa I. Pilkington, Chae Yeon Jeon, Mirae Song, Ling-Mey Gridel, Euphemia Leung, David Barker, Milena Vuica-Ross, Konstantin P. Volcho, et al, “A Synthesis, In Silico, In Vitro and In Vivo Study of Thieno[2,3-b]Pyridine Anticancer Analogues,” MedChemComm 6, no. 11 (2015): 1987–97. doi:10.1039/C5MD00245A.
  • S. A. Ahmed, O. M. Ahmed, and H. S. Elgendy, “Novel Synthesis of Puriensanalougues and Thieno[2,3-b] Pyridine Derivatives with Anticancer and Antioxidant Activity,” Journal of Pharmacy Research 8, no. 9 (2014): 1303–13.
  • Wenquan Yu, Cally Goddard, Elizabeth Clearfield, Courtney Mills, Tong Xiao, Haitao Guo, John D. Morrey, Neil E. Motter, Kang Zhao, Timothy M. Block, et al, “Design, Synthesis, and Biological Evaluation of Triazolo-Pyrimidine Derivatives as Novel Inhibitors of Hepatitis B Virus Surface Antigen (HBsAg) Secretion,” Journal of Medicinal Chemistry 54, no. 16 (2011): 5660–70. doi:10.1021/jm200696v.
  • Q. Chen, X.-L. Zhu, L.-L. Jiang, Z.-M. Liu, and G.-F. Yang, “Synthesis, Antifungal Activity and CoMFA Analysis of Novel 1,2,4-Triazolo[1,5-a]Pyrimidine Derivatives,” European Journal of Medicinal Chemistry 43, no. 3 (2008): 595–603. doi:10.1016/j.ejmech.2007.04.021.
  • R. H. Abd El-Aleam, R. F. George, G. S. Hassan, and H. M. Abdel-Rahman, “Synthesis of 1,2,4-Triazolo[1,5-a]Pyrimidine Derivatives: Antimicrobial Activity, DNA Gyrase Inhibition and Molecular Docking ,” Bioorganic Chemistry 94 (2020): 103411. doi:10.1016/j.bioorg.2019.103411.
  • N. M. Abunada, H. M. Hassaneen, N. G. Kandile, and O. A. Miqdad, “Synthesis and Antimicrobial Activity of Some New Pyrazole, Fused Pyrazolo[3,4-d]-Pyrimidine and Pyrazolo[4,3-e][1,2,4]-Triazolo[1,5-c]Pyrimidine Derivatives,” Molecules (Basel, Switzerland) 13, no. 7 (2008): 1501–17. doi:10.3390/molecules13071501.
  • F. A. Eid, A. El-Wahab, G.-H. Ali, and M. M. Khafagy, “Synthesis and Antimicrobial Evaluations of Naphtho[2,1-b]Pyrano[2,3-d]-Pyrimidine and Pyrano[3,2-e][1,2,4]Triazolo[1,5-c]Pyrimidine Derivatives,” Acta Pharmaceutica-Zagreb 54, no. 1 (2004): 13–26.
  • A. H. Bedair, H. A. Emam, N. A. El-Hady, K. A. R. Ahmed, and A. M. El-Agrody, “Synthesis and Antimicrobial Activities of Novel Naphtho[2,1-b]Pyran, Pyrano[2,3-d]Pyrimidine and Pyrano[3,2-e][1,2,4]Triazolo[2,3-c]-Pyrimidine Derivatives,” Il Farmaco 56, no. 12 (2001): 965–73. doi:10.1016/S0014-827X(01)01168-5.
  • S. M. Gomha, A. M. G. Mohamed, Y. H. Zaki, M. M. Ewies, and S. A. Elroby, “Structural Elucidation and Antimicrobial Evaluation of Novel[1,2,4]Triazolo[4,3‐a] Pyrimidines and Pyrido[2,3‐d][1,2,4]Triazolo[4,3‐a] Pyrimidinones,” Journal of Heterocyclic Chemistry 55, no. 5 (2018): 1147–56. doi:10.1002/jhet.3146.
  • A. O. Abdelhamid, M. A. Mohamed, and Y. H. Zaki, “Reactions with Hydrazonoyl Halides 59: Synthesis and Antimicrobial Activity of 2,3-Dihydro-1,3,4-Thiadiazole, Triazolino[4,3-a]Pyrimidine, and Pyrimido [1,2-b][1,2,4,5] Tetrazin-6-One Containing Benzofuran Moiety,” Phosphorus, Sulfur, and Silicon and the Related Elements 183, no. 7 (2008): 1746–54. doi:10.1080/10426500701734265.
  • A. O. Abdelhamid, A. R. Sayed, and Y. H. Zaki, “Reaction of Hydrazonoyl Halides 511: A Facile Synthesis of 5-Arylthiazoles and Triazolino[4,3-a] Pyrimidines as Antimicrobial Agents,” Phosphorus, Sulfur, and Silicon and the Related Elements 182, no. 7 (2007): 1447–57. doi:10.1080/10426500701242145.
  • P. G. Baraldi, B. Cacciari, R. Romagnoli, G. Spalluto, K.-N. Klotz, E. Leung, K. Varani, S. Gessi, S. Merighi, and P. A. Borea, “ Pyrazolo[4,3-e]-1,2,4-Triazolo[1,5-c]Pyrimidine Derivatives as Highly Potent and Selective Human A(3) Adenosine Receptor Antagonists,” Journal of Medicinal Chemistry 42, no. 22 (1999): 4473–8. doi:10.1021/jm991114s.
  • A. M. Mohamed, H. R. M. Al-Qalawi, W. A. El-Sayed, W. A. A. Arafa, M. S. Alhumaimess, and A. K. Hassan, “Anticancer Activity of Newly Synthesized Triazolopyrimidine Derivatives and Their Nucleoside Analogs,” Acta Poloniae Pharmaceutica Drug Research 72 (2015): 307–18.
  • P. G. Baraldi, B. Cacciari, S. Moro, G. Spalluto, G. Pastorin, T. Da Ros, K.-N. Klotz, K. Varani, S. Gessi, and P. A. Borea, “Synthesis, Biological Activity, and Molecular Modeling Investigation of New Pyrazolo[4,3-e]-1,2,4-Triazolo[1,5-c]Pyrimidine Derivatives as Human A(3) Adenosine Receptor Antagonists,” Journal of Medicinal Chemistry 45, no. 4 (2002): 770–80. doi:10.1021/jm0109614.
  • Z. H. Khalil, A. A. A. Hafez, and A. A. Ahmed, “New Pyrimidine Derivatives: Synthesis and Application of Thiazolo[3,2-a]-Triazolo[4,3-a]-Pyrimidine as Bactericides, Fungicides and Bioregulators,” Phosphorus, Sulfur, and Silicon and the Related Elements 45, no. 1–2 (1989): 81–93. doi:10.1080/10426508908046079.
  • M. A. Mohamed, E. K. A. Abdelall, Y. H. Zaki, and A. O. Abdelhamid, “Synthesis of Some New of Thieno[2,3-b] Pyridines, Pyrazolo[1,5-a]Pyrimidine,[1,2,4]Triazolo[1,5-a]Pyrimidine, Pyrazolo [5,1-c]Triazine and Pyrimido[1,2-a]Benzimidazole Derivatives Containing Pyridine Moiety,” European Journal of Chemistry 2, no. 4 (2011): 509–13. doi:10.5155/eurjchem.2.4.509-513.463.
  • Y. H. Zaki, S. A. Ahmed, A. M. Hussein, and A. O. Abdelhamid, “Reactions of Hydrazonoyl Halides 47: Synthesis of Some New 2,3-Dihydro-1,3,4-Thiadiazoles, Triazolo [4,3-a] Pyrimidines, and Pyrazolo [3,4-d] Pyridazines with Expected Biological Activity,” Phosphorus, Sulfur, and Silicon and the Related Elements 181, no. 4 (2006): 825–37. doi:10.1080/10426500500272079.
  • A. O. Abdelhamid, A. H. Elghandour, A. M. Hussein, and Y. H. Zaki, “Reactions of Hydrazonoyl Halides 41: Synthesis of 1,2,4-Triazoles, 2,3-Dihydro-1,3,4-Thiadiazoles, and Triazolo[4,3-a]Pyrimidines”. Phosphorus, Sulfur, and Silicon and the Related Elements 180, no. 9 (2005): 2097–109. doi:10.1080/104265090917448.
  • A. O. Abdelhamid, A. H. El-Ghandour, A. M. Hussein, and Y. H. Zaki, “Reactions of Hydrazonoyl Halides 44 [1]: Synthesis of Some New 1,3,4-Thiadiazolines, 1,3,4-Selenadiazolines and Triazolino[4,3-a]Pyrimidines,” Journal of Sulfur Chemistry 25, no. 5 (2004): 329–42. doi:10.1080/17415990412331304139.
  • Y. H. Zaki, A. O. Abdelhamid, A. R. Sayed, and H. S. Mohamed, “Synthesis of 1,3,4-Thiadiazole Derivatives Using Hydrazonoyl Bromide: Molecular Docking and Computational Studies,” Polycyclic Aromatic Compounds (2022): 1–14. doi:10.1080/10406638.2022.2027791.
  • M. A. Nassan, A. Aldhahrani, H. H. Amer, A. Elhenawy, A. A. Swelum, O. M. Ali, and Y. H. Zaki, “Investigation of the Anticancer Effect of Alpha;-Aminophosphonates and Arylidine Derivatives of 3-Acetyl-1-Aminoquinolin-2(1H)-One on the DMBA Model of Breast Cancer in Albino Rats with In Silico Prediction of Their Thymidylate Synthase Inhibitory Effect,” Molecules 27, no. 3 (2022): 756. doi:10.3390/molecules27030756.
  • S. A. Fouad, M. S. El-Gendey, E. M. Ahmed, S. A. Hessein, Y. A. Ammar, and Y. H. Zaki, “Convenient Synthesis of Some New Thiophene, Pyrazole, and Thiazole Derivatives Bearing Biologically Active Sulfonyl Guanidine Moiety,” Polycyclic Aromatic Compounds (2021): 1–19. doi:10.1080/10406638.2021.1988999.
  • A. O. Abdelhamid, I. E. El Sayed, Y. H. Zaki, A. M. Hussein, M. M. Mangoud, and M. A. Hosny, “Utility of 5-(Furan-2-yl)-3-(p-Tolyl)-4,5-Dihydro-1H-Pyrazole-1-Carbothioamide in the Synthesis of Heterocyclic Compounds with Antimicrobial Activity,” BMC Chemistry 13, no. 1 (2019): 48. doi:10.1186/s13065-019-0566-y.
  • C. L. Perrin and D. B. Young, “Is the Isomer with the Largest Dipole Moment Always the Least Stable?” Tetrahedron Letters 36, no. 40 (1995): 7185–8. doi:10.1016/0040-4039(95)01492-Z.
  • A. M. Asiri, M. E. M. Zayed, and S. W. Ng, “Ethyl 2-Chloro-[2-(4-chloro-phen-yl)Hydrazin-1-yl-idene]Acetate ,” Acta Crystallographica. Section E, Structure Reports Online 66, no. Pt 9 (2010): o2375. doi:10.1107/S1600536810032599.
  • N. F. Eweiss and A. Osman, “Synthesis of Heterocycles. Part II. New Routes to Acetylthiadiazolines and Alkylazothiazoles,” Journal of Heterocyclic Chemistry 17, no. 8 (1980): 1713–7. doi:10.1002/jhet.5570170814.
  • A. S. Shawali and A. O. Abdelhamid, “Reaction of Dimethylphenacylsulfonium Bromide with N-Nitrosoacetarylamides and Reactions of the Products with Nucleophiles,” Bulletin of the Chemical Society of Japan 49, no. 1 (1976): 321–4. doi:10.1246/bcsj.49.321.
  • A. Shawali and A. Osman, “Synthesis and Reactions of Phenylcarbamoylarylhydrazidic Chlorides,” Tetrahedron 27, no. 12 (1971): 2517–28. doi:10.1016/S0040-4020(01)90753-7.
  • D. S. Biovia, Discovery Studio Modeling Environment, Release 2017., San Diego: Dassault Systèmes. In.: Version (2016).
  • O. Trott and A. J. Olson, “AutoDock Vina: Improving the Speed and Accuracy of Docking with a New Scoring Function, Efficient Optimization, and Multithreading,” Journal of Computational Chemistry 31, no. 2 (2010): 455–61. doi:10.1002/jcc.21334.
  • R. N. Sharma, K. P. Sharma, and S. N. Dixit, “Synthesis, Characterization, and Biological Activities of Some New Arylazopyrazoles,” Oriental Journal of Chemistry 26, no. 1 (2010): 283.
  • L. Studennikova, “Hydrazones of Acetaceric Ester,” SbNauch Ref Zh Kim 1, no. 7173 (1969): 46.
  • M. Amir, and R. Agarwal, “Synthesis and Antibacterial Activity of 1‐Thiocarbamoyl‐3‐Methyl‐4‐(Arylhydrazono)‐2‐Pyrazolin‐5‐One,” ChemInform 29, no. 27 (2010). doi:10.1002/chin.199827139.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.